Researcher
Hans Wildiers
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 27
- Breast cancer projectFrom1 Jan 2024 → TodayFunding: Other federal public and semi-governmental institutions
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Building a large blood biobank of patients with new breast cancer diagnosis for future researchFrom1 Jan 2022 → 5 Jun 2023Funding: Other federal public and semi-governmental institutions
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- The impact of coaching on quality of life of older cancer patientsFrom27 Sep 2021 → 31 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patientsFrom1 Apr 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Mechanisms involved in metastasis of luminal breast cancerFrom1 Mar 2021 → 28 Feb 2022Funding: Foundations, funds and other with scientific goal
- The MBC biobank collection.From1 Dec 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Risk prediction and modeling of cancer therapy related cardiotoxicityFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Sep 2020 → 13 Feb 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 473
- The added value of supervised hydrotherapy sessions to a 12- week exercise program after breast cancer treatment: a three- arm pseudo-randomized pilot study(2023)
Authors: An De Groef, Inge Geraerts, Koen Peers, Hans Wildiers
- Challenging the current 1-10% cut-off for defining Estrogen Receptor Low Positive grade 2-3 Estrogen Receptor positive, Human Epidermal growth factor Receptor 2 negative early breast cancer(2023)
Authors: Beppe Floris, Christine Desmedt, Ines Nevelsteen, Hans Wildiers, Patrick Neven
- Real world adjuvant endocrine treatment in premenopausal breast cancer patients compared with the proposed algorithm using the Regan Composite Risk Score(2023)
Authors: Patrick Neven, Annouschka Laenen, Hans Wildiers, Ines Nevelsteen, Sileny Han, Eva Oldenburger, Christine Desmedt
- Stromal tumor infiltrating lymphocytes and pathological complete response in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy(2023)
Authors: Maxim De Schepper, François Richard, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Beppe Floris, Christine Desmedt
- Breast cancer characteristics in premenopausal women by contraception method(2023)
Authors: Karen Van Baelen, Annouschka Laenen, Ines Nevelsteen, Hans Wildiers, Patrick Neven
- ctDNA detection in seven different types of body liquids in patients with metastatic breast cancer(2023)
Authors: François Richard, Tatjana Geukens, Maxim De Schepper, Karen Van Baelen, Anirudh Pabba, Sigrid Hatse, Bram Boeckx, Diether Lambrechts, Ines Nevelsteen, Patrick Neven, et al.
- Evaluation of changes in sequencing quality and transcriptomic profiles with increasing post-mortem interval: results from an optimization experiment within the UPTIDER tissue donation program(2023)
Authors: François Richard, Tatjana Geukens, Wouter Van Den Bogaert, Maxim De Schepper, Karen Van Baelen, Anirudh Pabba, Bram Boeckx, Diether Lambrechts, Ines Nevelsteen, Patrick Neven, et al.
- Obesity-associated changes in transcriptomic profile and immune landscape of primary breast cancer revealed by bulk and single-cell gene expression data(2023)
Authors: Tatjana Geukens, Karen Van Baelen, Maxim De Schepper, Hanne Vos, Patrick Neven, Ines Nevelsteen, Hans Wildiers, Beppe Floris, Diether Lambrechts, François Richard, et al.
- Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes(2023)
Authors: Victoria Depoorter, Koen Milisen, Johan Flamaing, Cindy Kenis, Hans Wildiers
- The impact of parity and age of first full term pregnancy on the prevalence of invasive lobular carcinoma in patients with breast cancer(2023)
Authors: Karen Van Baelen, François Richard, Beppe Floris, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Christine Desmedt